Fbxo7 Expression Promotes Lymphomagenesis
Author Information
Author(s): Lomonosov Mikhail, Meziane El Kahina, Ye Hongtao, Nelson David E., Randle Suzanne J., Laman Heike
Primary Institution: Department of Pathology, University of Cambridge, Cambridge, United Kingdom
Hypothesis
Does increased expression of Fbxo7 in hematopoietic stem and progenitor cells promote lymphomagenesis, particularly in the absence of p53?
Conclusion
Increased Fbxo7 expression in p53 null hematopoietic stem and progenitor cells significantly promotes the incidence of T cell lymphoma.
Supporting Evidence
- Increased Fbxo7 expression suppressed colony formation in hematopoietic stem and progenitor cells.
- Fbxo7 expression enhanced the proliferative capacity of p53 null cells.
- Mice reconstituted with p53 null cells expressing Fbxo7 showed a significant increase in T cell lymphoma incidence.
Takeaway
Fbxo7 is a protein that can help cancer grow, especially when another protein called p53 is missing. This study shows that more Fbxo7 can lead to more T cell cancer.
Methodology
The study involved retroviral transduction of Fbxo7 into wild-type and p53 null hematopoietic stem and progenitor cells, followed by in vitro and in vivo assays to assess colony formation, proliferation, and tumorigenesis.
Potential Biases
Potential bias in the interpretation of results due to the specific genetic backgrounds used in the study.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human conditions.
Participant Demographics
Mice were used as the primary model organism, specifically E13.5 mouse embryos for hematopoietic stem and progenitor cells.
Statistical Information
P-Value
0.0304
Statistical Significance
p=0.0304
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website